SO
SONX.US Sonendo Inc
- Market cap
- USD 6.10M
- P/E
- -
- P/B
- 1.18x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is SONX.US undervalued?
Graham numberThe Graham number of Sonendo Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Sonendo Inc fundamental analysis
No fundamental analysis for Sonendo Inc yet.
Sonendo Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Sonendo Inc
Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment technology platform designed for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sone…
Full company profileSonendo Inc financial statements
Sonendo Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 34.7M | 23.4M | 33.2M | 41.7M | 43.9M | 31.7M | 28.6M |
| Gross Profit | 9.07M | 3.89M | 8.34M | 10.5M | 10.7M | 11.8M | 12.0M |
| Operating Income | -45.5M | -43.3M | -44.1M | -58.2M | -57.7M | -29.4M | -13.5M |
| EBITDA | -43.5M | -39.1M | -41.1M | -55.4M | -54.8M | -26.6M | -12.6M |
| Net Income | -49.3M | -46.7M | -48.5M | -57.1M | -60.9M | -28.0M | -14.4M |
| EPS | -41 | -2.53 | -2.14 | -1.27 | -0.65 | -0.59 | -3.02 |
| Balance Sheet | |||||||
| Total Assets | 119M | 76.1M | 115M | 137M | 78.2M | 31.3M | 18.8M |
| Total Liabilities | 328M | 330M | 43.4M | 55.3M | 49.7M | 26.1M | 21.2M |
| Shareholders' Equity | -209M | -254M | 72.1M | 82.0M | 28.4M | 5.19M | -2.32M |
| Cash & Short-term Investments | 92.2M | 51.7M | 84.6M | 91.4M | 46.8M | 11.6M | 5.01M |
| Total Debt | 28.9M | 31.8M | 29.3M | 39.0M | 40.4M | 18.9M | 16.2M |
| Cash Flow | |||||||
| Operating Cash Flow | -49.1M | -38.5M | -48.6M | -61.1M | -46.1M | -24.7M | -11.0M |
| Capital Expenditure | 3.70M | 916K | 1.97M | 1.36M | 929K | 161K | 0.00 |
| Free Cash Flow | -52.8M | -39.5M | -50.6M | -62.4M | -47.0M | -24.8M | -11.0M |
| Ratios | |||||||
| ROE | - | - | -67.3% | -69.6% | -214.4% | -540.0% | - |
| ROA | -41.3% | -61.3% | -42.0% | -41.6% | -77.9% | -89.7% | -76.5% |
| Net Profit Margin | -141.9% | -199.8% | -146.1% | -137.0% | -138.9% | -88.4% | -50.5% |
| Debt to Equity | - | - | 0.41x | 0.48x | 1.42x | 3.65x | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Sonendo Inc dividends
Sonendo Inc has not paid dividends in the last 7 fiscal years.
Last stock split: 1:200 on Nov 8, 2024.
Who owns Sonendo Inc
- Insiders 1.06%
- Institutions 0.00%
- Public & others 98.94%
- Shares outstanding 4.76M
- Free float 424K
Top funds holding SONX.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Meridian Small Cap Growth Legacy | 3.85M | 7.10% | -1.38% | Sep 2023 |
| ArrowMark Small Cap Gro | 1.37M | 2.52% | -64.51% | Dec 2023 |
| Bridgeway Ultra-Small Company Market | 182K | 0.33% | 0.00% | Sep 2023 |
| SEI Small Cap Growth F (SIMT) | 162K | 0.30% | 0.00% | Dec 2023 |
| Federated Hermes Prudent Bear A | 120K | 0.22% | 0.00% | Sep 2023 |
| Federated Hermes Alternative Bear Eq. | 120K | 0.22% | 0.00% | Dec 2023 |
| Vanguard Instl Ttl Stck Mkt Idx Tr | 34.5K | 0.06% | -97.65% | Oct 2023 |
| SEI Small Cap II A (SIIT) | 27.1K | 0.05% | -11.55% | Dec 2023 |
| BlackRock Extended Mkt Composite | 501.00 | 0.00% | 0.00% | Sep 2023 |
Top institutions holding SONX.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| ArrowMark Colorado Holdings, LLC (ArrowMark Partners) | 5.85M | 10.78% | -1.73% | Sep 2023 |
| PURA VIDA INVESTMENTS, LLC | 4.66M | 8.59% | -0.18% | Sep 2023 |
| Blue Water Life Science Advisors, LLC | 4.64M | 8.55% | 0.00% | Sep 2023 |
| First Light Asset Management, LLC | 4.19M | 7.71% | 0.00% | Sep 2023 |
| Driehaus Capital Management LLC | 3.84M | 7.08% | 0.00% | Sep 2023 |
| Vanguard Group Inc | 2.03M | 3.73% | +0.06% | Sep 2023 |
| Masters Capital Management LLC | 1.75M | 3.22% | 0.00% | Sep 2023 |
| Yu Fan | 548K | 1.01% | 0.00% | Sep 2023 |
| Redmile Group, LLC | 410K | 0.76% | -17.61% | Sep 2023 |
| Wedbush Morgan Securities Inc | 394K | 0.73% | +14.31% | Sep 2023 |
| Geode Capital Management, LLC | 374K | 0.69% | +13.94% | Sep 2023 |
| Millennium Management LLC | 294K | 0.54% | -0.69% | Sep 2023 |
| JPMorgan Chase & Co | 220K | 0.41% | -13.39% | Sep 2023 |
| BOOTHBAY FUND MANAGEMENT, LLC | 185K | 0.34% | 0.00% | Sep 2023 |
| Bridgeway Capital Management, LLC | 182K | 0.33% | 0.00% | Sep 2023 |
| Morgan Stanley - Brokerage Accounts | 171K | 0.32% | +1.07% | Sep 2023 |
| CPV Partners, LLC | 149K | 0.28% | 0.00% | Sep 2023 |
| BlackRock Inc | 122K | 0.23% | +4.29% | Sep 2023 |
| Federated Hermes Inc | 120K | 0.22% | 0.00% | Sep 2023 |
| M&T Bank Corp | 91.4K | 0.17% | 0.00% | Sep 2023 |
Sonendo Inc company profile
- Company name
- Sonendo Inc
- Ticker
- SONX.US
- Exchange
- USA Stocks
- Listed since
- Oct 29, 2021
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 129
- Fiscal year end
- December
- Address
- 26061 Merit Circle, Laguna Hills, CA, United States, 92653
- Phone
- 949 766 3636
- Website
- sonendo.com
About Sonendo Inc
Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment technology platform designed for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid EDTA that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software to enable an integrated digital office for endodontists. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. Sonendo, Inc. was incorporated in 2006 and is headquartered in Laguna Hills, California.
Sonendo Inc management
5- Mr. Bjarne BergheimPresident, CEO & Director · born 1975
- Mr. John P. McGaughChief Operating Officer · born 1966
- Mr. Olav B. BergheimExecutive Director · born 1950
- Mr. Chris GuoCFO & Vice President of Business Development · born 1976
- Mr. Robert GuyattSenior Vice President of Commercial